当前位置: X-MOL首页 › SCI期刊查询及投稿分析系统 › Bioorganic & Medicinal Chemistry Letters杂志
Bioorganic & Medicinal Chemistry Letters
基本信息
期刊名称 | Bioorganic & Medicinal Chemistry Letters BIOORG MED CHEM LETT |
---|---|
期刊ISSN | 0960-894X |
期刊官方网站 | https://www.sciencedirect.com/journal/bioorganic-and-medicinal-chemistry-letters |
是否OA | No |
出版商 | Elsevier Ltd |
出版周期 | Semimonthly |
文章处理费 | 登录后查看 |
始发年份 | 1991 |
年文章数 | 288 |
影响因子 | 2.5(2023) scijournal影响因子 greensci影响因子 |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | CHEMISTRY, MEDICINAL 药物化学3区 | 否 | 否 |
CHEMISTRY, ORGANIC 有机化学3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 5.7 | 0.508 | 0.631 |
Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science |
61/183 | 66% |
|||
Chemistry Organic Chemistry |
74/211 | 65% |
|||
Biochemistry, Genetics and Molecular Biology Clinical Biochemistry |
50/117 | 57% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
74/157 | 53% |
|||
Biochemistry, Genetics and Molecular Biology Biochemistry |
219/438 | 50% |
补充信息
自引率 | 4% |
---|---|
H-index | 133 |
SCI收录状况 |
Science Citation Index Expanded |
官方审稿时间 | 登录后查看 |
网友分享审稿时间 | 数据统计中,敬请期待。 |
接受率 | 登录后查看 |
PubMed Central (PMC) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0960-894X%5BISSN%5D |
投稿指南
期刊投稿网址 | https://www.editorialmanager.com/BMCL |
---|---|
收稿范围 | BMCL (Bioorganic & Medicinal Chemistry Letters) publishes research communications of outstanding significance and timeliness on topics at the interface of chemistry and biology, together with concise review articles and perspectives. BMCL publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of BMCL is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. BMCL continues to be a major forum for the first publication of new chemical entities prior to them entering clinical trials. BMCL welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets The reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting Manuscripts on phytochemistry, theoretical molecular dynamics and exclusively computational papers are out of scope. All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMCL is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field. |
收录体裁 | |
投稿指南 | https://www.sciencedirect.com/journal/bioorganic-and-medicinal-chemistry-letters/publish/guide-for-authors |
投稿模板 | |
参考文献格式 | https://www.elsevier.com/journals/bioorganic-and-medicinal-chemistry-letters/0960-894x/guide-for-authors |
编辑信息 |
我要分享 (欢迎您来完善期刊的资料,分享您的实际投稿经验)